About Us

sphingotec GmbH develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury and circulatory shock, in order to support patient management and provide guidance for treatment strategies. Furthermore, sphingotec develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases and breast cancer, in order to support prevention strategies. Read More...
 
 

A UNIQUE WAY OF DISCOVERING DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS

SPHINGOTEC GROUP

COMBINING INNOVATIVE BIOMARKER WITH OUTSTANDING TECHNOLOGY

sphingotec
NexusDX

 

LATEST NEWS

  • sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology

    sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology

  • Endothelial disruption: Rapid translation from bench to bedside 

    Endothelial disruption: Rapid translation from bench to bedside 

  • sphingotec raises €20 million from HBM and Wellington Partners

    sphingotec raises €20 million from HBM and Wellington Partners

  • sphingotec is adding an advanced POC testing platform to portfolio

    sphingotec is adding an advanced POC testing platform to portfolio

previous arrow
next arrow
Slider

 

BIOMARKER

Sphingotest penKid
sphingotest® penKid®
Sphingotest bio-ADM
sphingotest® bio-ADM®

 
 

A UNIQUE WAY OF DISCOVERING DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS

 
 

OUR PARTNERS

 

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help. Privacy Policy | Imprint

Select an option to continue

Your selection was saved!

More information

Help

To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set. Borlabs Cookie already set a necessary cookie.

You can change your cookie setting here anytime: Privacy Policy. Imprint

Back

Top